Cipla Reports Q2FY27 Financial Results
Cipla Ltd 路 Investor Presentation 路 27 Oct 2026, 7:10 pm
Cipla Reports Q2FY27 Financial Results Cipla reported consolidated revenue from operations of INR 7,404 Cr for Q2FY27, down from INR 7,589 Cr in Q2FY26. EBITDA stood at INR 1,388 Cr with an 18.7% margin, compared to INR 1,895 Cr (25.0% margin) YoY, while PAT declined to INR 878 Cr (11.9% margin) from INR 1,351 Cr. One India delivered record quarterly revenue of INR 3,516 Cr, up 12% YoY. North America contributed $172 Mn, bolstered by US FDA approval for generic Advair Diskus across all strengths. R&D spending reached INR 423 Cr (5.7% of revenue).
Original exchange filing (PDF)
More announcements from Cipla Ltd
- Please find enclosed intimation 路 18 Nov 2026
- Please find enclosed disclosure. 路 17 Nov 2026
- Appointment of Mr Vikram Janakiraman, as the Global Chief Technical Operating Officer, designated as a Senior Management Personnel of the Company, with effect from 7th December, 2026. 路 04 Nov 2026
- Please find enclosed Earnings Call Transcript - Q2FY27 路 30 Oct 2026
- In compliance with the provisions of Regulation 30 of SEBI (LODR) Regulations, 2015, we hereby notify that the Operations and Administrative Committee of the Company on 29th October, 2026 .... 路 30 Oct 2026
- Pursuant to Regulation 30 read with Part A of Schedule III and Regulation 46 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the audio recording of the .... 路 28 Oct 2026
- Please find intimation in relation to grant of ESOS and ESAR. 路 27 Oct 2026
- Please find enclosed the intimation for Appointment of Ms Rashmi Joshi as an additional and independent director of the Company w.e.f. 27th October, 2026 for a period of 5 years. 路 27 Oct 2026
